Age ≥18 year; histologically confirmed resectable G/GEJ adenocarcinoma (stage II-IVA); ECOG PS 0-1; adequate organ function; tumor sample for PD-L1 testing; no prior anticancer therapy. The gene discussed is CD274; the disease is gastroesophageal junction adenocarcinoma.